MiR-21 overexpression improves osteoporosis by targeting RECK

Molecular and Cellular Biochemistry

Volumn 405, Issue 1-2, 2015, Pages 125-133

  Zhao, Weigong ^a   Dong, Yanying ^a   Wu, Caijun ^a   Ma, Yunfeng ^a   Jin, Yaofeng ^a   Ji, Yanhong ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

miR 21; MT1 MMP; Osteoporosis; RECK

Indexed keywords

ALKALINE PHOSPHATASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE 14; MICRORNA 21; OSTEOCALCIN; PROTEIN; REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL MOTIF; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MICRORNA; RECK PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE DENSITY; BONE MINERAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; IN VIVO STUDY; LUCIFERASE ASSAY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; PROTEIN FUNCTION; ANIMAL; BONE DEVELOPMENT; C57BL MOUSE; CELL LINE; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM;

MUS;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; BONE DENSITY; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; FEMALE; GPI-LINKED PROTEINS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICRORNAS; OSTEOCALCIN; OSTEOGENESIS; OSTEOPOROSIS; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929964523     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-015-2404-4     Document Type: Article

References (31)

1. Weinstein RS, Manolagas SC (2000) Apoptosis and osteoporosis. Am J Med 108:153–164
2. Rana TM (2007) Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol 8:23–36. doi:10.1038/nrm2085
3. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
4. van Wijnen AJ, van de Peppel J, van Leeuwen JP, Lian JB, Stein GS, Westendorf JJ, Oursler MJ, Im HJ, Taipaleenmaki H, Hesse E, Riester S, Kakar S (2013) MicroRNA functions in osteogenesis and dysfunctions in osteoporosis. Curr Osteoporos Rep 11:72–82. doi:10.1007/s11914-013-0143-6
5. Jia J, Tian Q, Ling S, Liu Y, Yang S, Shao Z (2013) miR-145 suppresses osteogenic differentiation by targeting Sp7. FEBS Lett 587:3027–3031. doi:10.1016/j.febslet.2013.07.030
6. Shi K, Lu J, Zhao Y, Wang L, Li J, Qi B, Li H, Ma C (2013) MicroRNA-214 suppresses osteogenic differentiation of C2C12 myoblast cells by targeting Osterix. Bone 55:487–494. doi:10.1016/j.bone.2013.04.002
7. Li E, Zhang J, Yuan T, Ma B (2014) MiR-143 suppresses osteogenic differentiation by targeting Osterix. Mol Cell Biochem 390:69–74. doi:10.1007/s11010-013-1957-3
8. Kang IH, Jeong BC, Hur SW, Choi H, Choi SH, Ryu JH, Hwang YC, Koh JT (2015) MicroRNA-302a stimulates osteoblastic differentiation by repressing COUP-TFII expression. J Cell Physiol 230:911–921. doi:10.1002/jcp.24822
9. Zhang F, Yang Z, Cao M, Xu Y, Li J, Chen X, Gao Z, Xin J, Zhou S, Zhou Z, Yang Y, Sheng W, Zeng Y (2014) MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer. Cancer Lett 342:121–129. doi:10.1016/j.canlet.2013.08.037
10. Gong C, Nie Y, Qu S, Liao JY, Cui X, Yao H, Zeng Y, Su F, Song E, Liu Q (2014) miR-21 induces myofibroblast differentiation and promotes the malignant progression of breast phyllodes tumors. Cancer Res 74:4341–4352. doi:10.1158/0008-5472.CAN-14-0125
11. Li B, Ren S, Li X, Wang Y, Garfield D, Zhou S, Chen X, Su C, Chen M, Kuang P, Gao G, He Y, Fan L, Fei K, Zhou C, Schmit-Bindert G (2014) MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer. Lung Cancer 83:146–153. doi:10.1016/j.lungcan.2013.11.003
12. Liu J, Zhu H, Yang X, Ge Y, Zhang C, Qin Q, Lu J, Zhan L, Cheng H, Sun X (2014) MicroRNA-21 is a novel promising target in cancer radiation therapy. Tumour Biol 35:3975–3979. doi:10.1007/s13277-014-1623-8
13. Yang N, Wang G, Hu C, Shi Y, Liao L, Shi S, Cai Y, Cheng S, Wang X, Liu Y, Tang L, Ding Y, Jin Y (2013) Tumor necrosis factor alpha suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis. J Bone Miner Res 28:559–573. doi:10.1002/jbmr.1798
14. Mei Y, Bian C, Li J, Du Z, Zhou H, Yang Z, Zhao RC (2013) miR-21 modulates the ERK-MAPK signaling pathway by regulating SPRY2 expression during human mesenchymal stem cell differentiation. J Cell Biochem 114:1374–1384. doi:10.1002/jcb.24479
15. Fan X, Wang E, Wang X, Cong X, Chen X (2014) MicroRNA-21 is a unique signature associated with coronary plaque instability in humans by regulating matrix metalloproteinase-9 via reversion-inducing cysteine-rich protein with Kazal motifs. Exp Mol Pathol 96:242–249. doi:10.1016/j.yexmp.2014.02.009
16. Ziyan W, Shuhua Y, Xiufang W, Xiaoyun L (2011) MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med Oncol 28:1469–1474. doi:10.1007/s12032-010-9563-7
17. Mannello F, Tonti GA, Bagnara GP, Papa S (2006) Role and function of matrix metalloproteinases in the differentiation and biological characterization of mesenchymal stem cells. Stem Cells 24:475–481. doi:10.1634/stemcells.2005-0333
18. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, Ide C, Horan TP, Arakawa T, Yoshida H, Nishikawa S, Itoh Y, Seiki M, Itohara S, Takahashi C, Noda M (2001) The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107:789–800
19. Wu T, Xie M, Wang X, Jiang X, Li J, Huang H (2012) miR-155 modulates TNF-alpha-inhibited osteogenic differentiation by targeting SOCS1 expression. Bone 51:498–505. doi:10.1016/j.bone.2012.05.013
20. Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Investig 115:3318–3325. doi:10.1172/JCI27071
21. Clowes JA, Riggs BL, Khosla S (2005) The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev 208:207–227. doi:10.1111/j.0105-2896.2005.00334.x
22. Nanes MS (2003) Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 321:1–15
23. Dong J, Cui X, Jiang Z, Sun J (2013) MicroRNA-23a modulates tumor necrosis factor-alpha-induced osteoblasts apoptosis by directly targeting Fas. J Cell Biochem 114:2738–2745. doi:10.1002/jcb.24622
24. Wang Y, Gao X, Wei F, Zhang X, Yu J, Zhao H, Sun Q, Yan F, Yan C, Li H, Ren X (2014) Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis. Gene 533:389–397. doi:10.1016/j.gene.2013.09.038
25. Xu LF, Wu ZP, Chen Y, Zhu QS, Hamidi S, Navab R (2014) MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China. PLoS One 9:e103698. doi:10.1371/journal.pone.0103698
26. Wang N, Zhang CQ, He JH, Duan XF, Wang YY, Ji X, Zang WQ, Li M, Ma YY, Wang T, Zhao GQ (2013) MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma. Dig Dis Sci 58:1863–1870. doi:10.1007/s10620-013-2612-2
27. Ren W, Wang X, Gao L, Li S, Yan X, Zhang J, Huang C, Zhang Y, Zhi K (2014) MiR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4. Mol Cell Biochem 390:253–262. doi:10.1007/s11010-014-1976-8
28. Li C, Li C, Yue J, Huang X, Chen M, Gao J, Wu B (2012) miR-21 and miR-101 regulate PLAP-1 expression in periodontal ligament cells. Mol Med Rep 5:1340–1346. doi:10.3892/mmr.2012.797
29. Holmbeck K, Bianco P, Pidoux I, Inoue S, Billinghurst RC, Wu W, Chrysovergis K, Yamada S, Birkedal-Hansen H, Poole AR (2005) The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone. J Cell Sci 118:147–156. doi:10.1242/jcs.01581
30. Toth M, Chvyrkova I, Bernardo MM, Hernandez-Barrantes S, Fridman R (2003) Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. Biochem Biophys Res Commun 308:386–395
31. Manduca P, Castagnino A, Lombardini D, Marchisio S, Soldano S, Ulivi V, Zanotti S, Garbi C, Ferrari N, Palmieri D (2009) Role of MT1-MMP in the osteogenic differentiation. Bone 44:251–265. doi:10.1016/j.bone.2008.10.046